Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT (HepASA)
This study has been terminated.
( interim analysis found no difference in LB rate and lower than expected event rate )
Study NCT00564174 Information provided by Mount Sinai Hospital, Canada
First Received: November 26, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Pregnancy Loss
Antiphospholipid Antibody Syndrome
Additional conditions recognized in this trial
Antiphospholipid Syndrome
Recurrence
Syndrome
More general conditions related to this trial
Autoimmune Diseases
Disease
Disease Attributes
Immune System Diseases
Pathologic Processes
Interventions listed in this trial
Low dose aspirin
Additional drug interventions recognized in this trial
Aspirin
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mount Sinai Hospital, Canada
Canadian Institutes of Health Research (CIHR)
Pfizer
Back to top of Main Content
